Fundraising Fox

Pelage Pharmaceuticals

Los Angeles, US · Delaware corporation · 4 known investors

Biotech

Founders & leadership

WE
William Edward LowryCo-founder
DG
Daniel GilCo-founder
HC
Heather ChristofkCo-founder

Board

CF
Cathy FriedmanBoard director

Investors · 4

ARCH Venture PartnersreportedChicago · $50K – $250M
GV (Google Ventures)reportedMountain View · $250K – $50M
Visionary VenturesreportedNewport Beach · $5M – $15M
YK BioventuresreportedBurlingame

Reported raises · per SEC filings

Form D private placements

$150.7M disclosed across 3 rounds · 2023–2025

▶$120MraisedNov 2025 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cathy FriedmanDirector
  • Nathan WheelerExecutive Officer
  • William Edward LowryExecutive Officer, Director
  • Christina WengExecutive Officer
  • Daniel GilExecutive Officer, Director
  • Richard HeymanDirector
Offering amount
$120M
Amount sold
$120M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedAug 2024 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cathy FriedmanDirector
  • William Edward LowryDirector
  • Daniel GilExecutive Officer, Director
  • Heather ChristofkExecutive Officer
Offering amount
$14M
Amount sold
$14M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.7MraisedJun 2023 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cathy FriedmanDirector
  • Heather ChristofkExecutive Officer
  • William Edward LowryDirector
  • Daniel GilExecutive Officer, Director
Offering amount
$16.7M
Amount sold
$16.7M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Pelage Pharmaceuticals Phase 3 Trials for PP405 in 2026 | Hair Loss Cure 2020hairlosscure2020.com · Jul 2026Pelage Pharma Hair Regrowth: $120M for New PP405 Treatment - Los Angeles Timeslatimes.com · Apr 2026Pelage Pharmaceuticals raises $120M Series B for androgenetic alopecia treatmentaxios.com · Oct 2025Pelage Pharma raises $120 million to advance development of hair loss treatmentyahoo.com · Oct 2025Pelage Pharmaceuticals Raises $120M in Series B Financing - FinSMEsfinsmes.com · Oct 2025Pelage Pharma raises $120M series B to untangle roots of hair loss with regenerative medfiercebiotech.com · Oct 2025

Frequently asked questions

Who founded Pelage Pharmaceuticals?
Pelage Pharmaceuticals was founded by William Edward Lowry, Daniel Gil, Heather Christofk.
Who are Pelage Pharmaceuticals's investors?
Pelage Pharmaceuticals's investors include ARCH Venture Partners, GV (Google Ventures), Visionary Ventures, YK Bioventures.
How much funding has Pelage Pharmaceuticals raised?
Pelage Pharmaceuticals has disclosed $150.7M raised across 3 rounds.
Where is Pelage Pharmaceuticals headquartered?
Pelage Pharmaceuticals is headquartered in Los Angeles, US.